IRIS
ORIO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.993
NA - Nord America 3.736
EU - Europa 2.496
SA - Sud America 495
AF - Africa 127
Continente sconosciuto - Info sul continente non disponibili 100
OC - Oceania 5
Totale 10.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.577
SG - Singapore 1.676
RU - Federazione Russa 1.285
CN - Cina 835
VN - Vietnam 800
BR - Brasile 396
HK - Hong Kong 323
IT - Italia 226
DE - Germania 201
NL - Olanda 150
FI - Finlandia 124
FR - Francia 124
IE - Irlanda 104
CA - Canada 83
SE - Svezia 81
GB - Regno Unito 69
IN - India 61
JP - Giappone 60
MX - Messico 43
AR - Argentina 39
CI - Costa d'Avorio 36
UA - Ucraina 36
BD - Bangladesh 33
IQ - Iraq 27
PL - Polonia 25
ZA - Sudafrica 25
ES - Italia 23
PH - Filippine 23
EC - Ecuador 21
ID - Indonesia 17
KR - Corea 17
TR - Turchia 17
PK - Pakistan 15
TH - Thailandia 15
DZ - Algeria 14
LT - Lituania 12
CZ - Repubblica Ceca 11
PY - Paraguay 10
TW - Taiwan 10
EG - Egitto 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
UZ - Uzbekistan 7
BE - Belgio 6
CL - Cile 6
CO - Colombia 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 6
NP - Nepal 6
SA - Arabia Saudita 6
KZ - Kazakistan 5
AU - Australia 4
GE - Georgia 4
GT - Guatemala 4
MA - Marocco 4
MW - Malawi 4
NG - Nigeria 4
PE - Perù 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
ET - Etiopia 3
HN - Honduras 3
KG - Kirghizistan 3
MU - Mauritius 3
QA - Qatar 3
RS - Serbia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AT - Austria 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
GR - Grecia 2
IL - Israele 2
LB - Libano 2
LC - Santa Lucia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SR - Suriname 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
CD - Congo 1
CG - Congo 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GP - Guadalupe 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
Totale 10.840
Salva come PNG Salva come JPEG
Città #
Singapore 762
San Jose 618
Hong Kong 310
Moscow 310
Beijing 303
Chandler 297
Ashburn 269
Ho Chi Minh City 224
Hanoi 186
Amsterdam 137
Millbury 133
Santa Clara 128
Los Angeles 115
Princeton 101
The Dalles 97
Lauterbourg 94
Naples 92
Nanjing 88
Jacksonville 75
Munich 71
New York 62
Boston 50
Dallas 49
Tokyo 49
Wilmington 49
São Paulo 46
Council Bluffs 42
Buffalo 41
Dong Ket 40
Seattle 38
Nanchang 37
Redondo Beach 37
Orem 31
Da Nang 30
Ottawa 27
Des Moines 26
Napoli 26
Helsinki 25
Atlanta 24
Mexico City 24
Chennai 23
Haiphong 23
Montreal 22
Chicago 21
Denver 20
Stockholm 20
Phoenix 17
Shenyang 17
Warsaw 17
Brooklyn 16
Turku 16
Frankfurt am Main 15
Tianjin 15
Houston 14
Hải Dương 14
Jiaxing 14
Falkenstein 13
Hebei 13
Johannesburg 13
London 13
Norwalk 13
Toronto 13
Biên Hòa 12
Changsha 12
Rio de Janeiro 12
San Francisco 12
Dublin 11
Milan 11
Poplar 11
Woodbridge 11
Can Tho 10
Guayaquil 10
Dearborn 9
Falls Church 9
Boardman 8
Guangzhou 8
Nha Trang 8
Redwood City 8
Rome 8
Shanghai 8
Thái Bình 8
Brno 7
Düsseldorf 7
Kunming 7
Madrid 7
Manchester 7
Milwaukee 7
Nuremberg 7
Phủ Lý 7
Pune 7
Washington 7
Ankara 6
Brasília 6
Dhaka 6
Hefei 6
Jakarta 6
Miami 6
São José do Rio Preto 6
Thái Nguyên 6
Algiers 5
Totale 5.834
Salva come PNG Salva come JPEG
Nome #
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 181
31. SIX MONTHS OF TREATMENT WITH CABERGOLINE RESTORES SEXUAL POTENCY IN HYPERPROLACTINEMIC MALES. AN OPEN LONGITUDINAL STUDY MONITORING NOCTURNAL PENILE TUMESCENCE. 172
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 161
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 161
Influence of nutrition on somatotropic axis: Milk consumption in adult individuals with moderate-severe obesity 158
Cardiopulmonary impairment in young women with polycystic ovary syndrome 156
BISPHENOL A IN POLYCYSTIC OVARY SYNDROME AND ITS ASSOCIATION WITH LIVER-SPLEEN AXIS. 155
Endocrine Aspects of Environmental "Obesogen" Pollutants 155
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. 151
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome 151
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 145
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 144
Calcium and vitamin D supplementation. Myths and realities with regard to cardiovascular risk 144
Low serum vitamin D-status, air pollution and obesity: A dangerous liaison 141
Insulin-Mediated Diseases: Adrenal Mass and Polycystic Ovary Syndrome 141
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. 139
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 137
Effects of neridronate treatment in elderly women with osteoporosis 136
EFFECTS OF PHYSICAL EXERCISE ON THE FEMALE REPRODUCTIVE SYSTEM. 136
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 135
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors. 134
Vitamin D and chronic diseases: the current state of the art 134
Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. 133
Lifestyle changes in the management of adulthood and childhood obesity. 132
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 131
Comment on Krul-Poel et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. Diabetes Care 2015;38:1420-1426 131
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in young women with polycystic ovary syndrome. 130
Evidence for altered adipocyte function in polycystic ovary syndrome 130
Low vitamin D status and obesity: Role of nutritionist 130
Cardiovascular complications of obesity in adolescents 128
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 128
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome 128
Adrenocortical tumors and insulin resistance: What is the first step? 128
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters 127
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial 125
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 125
Metabolic and cardiovascular consequences of polycystic ovary syndrome 124
Vitamin D and thyroid disease: To D or not to D? 124
THE GOOD AND BAD EFFECTS OF STATINS ON INSULIN SENSITIVITY AND SECRETION. 123
Failure of long-term therapy with sodium valproate in Cushing's disease. 122
Mechanisms in endocrinology: Vitamin D as a potential contributor in endocrine health and disease 120
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 119
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 119
Gut: A key player in the pathogenesis of type 2 diabetes? 119
Endothelial dysfunction in PCOS: role of obesity and adipose hormones 118
Endocrine disorders during the first year after autologous stem-cell transplant 118
The integrity of the Growth Hormone and Insuline-like Growth Factor -1 axis as outcome predictor after Laparoscopic Adjustable Silicone Gastric Banding. 117
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 117
Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance 115
Cardiovascular risk in women with polycystic ovary sydrome 114
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome 111
Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer 109
Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? 107
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome 105
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes 105
Effect of growth hormone on cardiac function 103
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine 102
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome 99
Water intake keeps type 2 diabetes away? Focus on copeptin 99
Polycystic ovary syndrome and obesity: non pharmacological approaches 98
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 94
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 89
Tianeptine, an antiserotoninergic drug, increases GHRH release into the hypophyseal portal blood of the sheep 89
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 84
Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome. 83
Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. 83
Nutrition, inflammation and liver-spleen axis 82
Androgens in polycystic ovary syndrome: the role of exercise and diet 81
DAI NUOVI CRITERI DIAGNOSTICI ALLE RECENTI ACQUISIZIONI TERAPEUTICHE DELLA SINDROME DELL’OVAIO POLICISTICO. 81
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene 80
Serum 25-Hydroxyvitamin D Levels, Phosphoprotein Enriched in Diabetes Gene Product (PED/PEA-15) and Leptin-to-Adiponectin Ratio in Women with PCOS. 79
Cardiovascular complications of obesity 78
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 77
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 77
Cardiovascular risk in women with polycystic ovary syndrome 77
Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study 76
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy 75
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 75
Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome 75
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 75
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study 73
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 73
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 72
STUDY OF HOMOCYSTEINE LEVELS AND C677T POLYMORPHISM OF MTHFR IN YOUNG WOMEN WITH PCOS. 72
LA SINDROME METABOLICA NELLA SINDROME DELL’OVAIO POLICISTICO: IL RUOLO DELL’ESERCIZIO FISICO. 71
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 70
L’esercizio fisico nei soggetti obesi. 67
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial 65
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS) 63
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study 62
Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. 62
Malattie Ipotalamo Ipofisarie- Tumori ipofisari secernenti 62
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept 62
Impaired cardiopulmonary parameters in young women with polycystic ovary syndrome 61
Favourable effects of exercise-based Cardiac Rehabilitation after acute myocardial infarction on left atrial remodeling 58
Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women 58
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 58
Relationships between inflammatory markers, visceral fat and maximal oxygen consumption in women with polycystic ovary syndrome. 58
Ovulation induction in women with polycystic ovary syndrome 55
Letter to the Editor: Vitamin D: A Wonder Drug for the Cure of Type 2 Diabetes? 54
Totale 10.666
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022609 0 3 0 6 4 58 2 11 98 28 126 273
2022/2023728 115 64 22 59 81 60 10 55 92 127 35 8
2023/2024486 24 76 118 15 16 38 3 64 3 4 77 48
2024/20252.676 135 132 29 28 50 157 292 170 174 273 1.013 223
2025/20265.421 603 326 528 532 923 223 695 351 659 367 100 114
2026/2027163 116 47 0 0 0 0 0 0 0 0 0 0
Totale 10.952